Table 1.
Blood tests were performed at 1 week after injury, in order to analyze the systemic effects of WP1066
| Control | WP1066 | P value | |
|---|---|---|---|
| N | 5 | 6 | |
| Leukocytes (109/L) | 3.72 ± 1.14 | 3.28 ± 0.97 | 0.511 |
| Erythrocytes (1012/L) | 8.94 ± 0.55 | 8.97 ± 0.69 | 0.537 |
| Hemoglobin (g/L) | 137.60 ± 9.40 | 131.67 ± 12.52 | 0.406 |
| Hematokrit (L/L) | 0.44 ± 0.04 | 0.44 ± 0.04 | 0.748 |
| Mean corpuscular volume (fL) | 49.60 ± 2.41 | 48.67 ± 1.63 | 0.464 |
| Mean corpuscular hemoglobin (pg) | 15.40 ± 0.85 | 14.68 ± 0.44 | 0.354 |
| Mean corpuscular hemoglobin concentration (g/dL) | 30.96 ± 1.51 | 30.17 ± 0.92 | 0.239 |
| Platelets (109/L) | 272.20 ± 89.19 | 513.17 ± 238.72 | 0.330 |
| Eosinophils (109/L) | 0.03 ± 0.06 | 0.01 ± 0.03 | 0.762 |
| Segmented Neutrophils (109/L) | 0.74 ± 0.41 | 0.54 ± 0.35 | 0.824 |
| Basophils (109/L) | 0.00 ± 0.00 | 0.00 ± 0.00 | 1.000 |
| Lymphocytes (109/L) | 2.98 ± 0.77 | 2.56 ± 0.88 | 0.760 |
| Monocytes (109/L) | 0.07 ± 0.14 | 0.06 ± 0.05 | 0.352 |
| Creatinine (mg/dL) | 0.10 ± 0.00 | 0.09 ± 0.04 | 0.762 |
| Albumin (g/L) | 22.75 ± 2.50 | 22.17 ± 3.06 | 0.760 |
| Lactate dehydrogenase (U/L) | 523.00 ± 97.97 | 458.40 ± 85.36 | 0.114 |
| Aspartate transaminase (U/L) | 142.00 ± 60.65 | 172.17 ± 61.93 | 0.469 |
| Alanine transaminase (U/L) | 25.50 ± 1.91 | 25.00 ± 4.15 | 0.830 |
There was no significant difference between vehicle (DMSO) and WP1066 treated mice